← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

▲ BUY
8 / 10

Conviction

$ Value

Shares

3,000

Price

Filed

May 19

Why this score? (8/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Goldan Keith A.

Title

Chief Financial Officer

CIK

0001495411

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

93,746

Footnotes

The purchase prices ranged from $8.8465 to $9.2825.

Filing Info

Accession No.

0000950170-25-074304

Form Type

4

Issuer CIK

0001395937

Goldan Keith A.'s History

Date Ticker Type Value
2026-04-01 ABEO A $0
2026-02-09 SNDX $72K
2026-02-06 SNDX $43K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $2.4M
2026-01-30 SNDX J $10K
2025-12-01 SNDX G $0
2025-07-31 SNDX J $10K
2025-07-16 SNDX $12K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04